News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Insider Information

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Not for distribution in the United States of America Berlin, Germany, September 20, 2017 – Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX, ISIN: DE0000A11QW50), announces that the Company is raising approximately EUR 5.5 million of gross proceeds in a share capital increase by way of private […]

Read more

Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG

PDF Publication of Inside Information according to Article 17 MAR August 7, 2017 – The Executive Board of Epigenomics AG (FSE: ECX; OTCQX: EPGNY) notifies that according to its best judgment a cumulative loss of more than half of the nominal share capital of the company has been incurred. This is mainly attributable to budgeted losses […]

Read more

Epigenomics AG issues change in guidance for financial year 2017

PDF July 6, 2017 – Epigenomics AG (FSE: ECX; OTCQX: EPGNY) today lowered its financial outlook for the financial year 2017. Based on lower than expected revenues in the first half of 2017 (H1 2017: approximately EUR 0.5 million), and the continued lack of reimbursement coverage anticipated for the remainder of the year in the U.S. […]

Read more

Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG

PDF April 26, 2017 – Epigenomics AG (FSE: ECX; OTCQX: EPGNY) (“Epigenomics” or “Company”), Cathay Fortune International Company Limited (“CFIC”) and Blitz F16-83 GmbH (in the future Summit Hero Holding GmbH, “Bidder”), a subsidiary of CFIC, have tonight entered into a business combination agreement (“BCA”) regarding the takeover of Epigenomics by the Bidder. Other than by CFIC, […]

Read more

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, November 16, 2016 – Epigenomics AG, Berlin, Germany (Prime Standard Segment, Frankfurt: ECX, ISIN: DE0000A11QW50), announces that the Company is raising EUR 2.1 million of gross […]

Read more

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, November 7, 2016 – Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX, ISIN: DE0000A11QW50), announces that the Company is raising close to EUR 5.0 million of […]

Read more
...